olivlawolivlaw

olivLaw · US equity research

Healthcare Services Group, Inc. HCSG

Services-Nursing & Personal Care Facilities · SIC 8050 · Vertical: Health services (SIC 805x)

26.54USD+3.79% · 1 dayClose 04 Nov 2026

Healthcare Services Group provides housekeeping, laundry, facility maintenance and dietary services to healthcare and long-term care facilities across the United States, and says it is the largest provider of such services to the long-term care industry. Its focus on institutional operational services has been tested by the bankruptcy of a major customer, yet the company reports accelerating growth, with revenue of 1,837.2 million USD in 2025 and 479.6 million USD in the third quarter of 2026.

At the close of 04 Nov 2026, Healthcare Services Group, Inc. (HCSG) stock was 26.54 USD (+3.79% on the day), with market capitalisation 1.8 bn USD, P/E 17.9 on diluted EPS of 1.49 USD over the last 12 months, dividend yield 3.24%, beta 0.74, 52-week range 17.02–26.54 USD. Latest reported quarter (Q3 2026): revenue of 479.6 m USD (+3.3% YoY), net income of 24.9 m USD (−42.1% YoY), diluted EPS 0.36 USD.

Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.

Market cap
1.8 bn USD
shares as of 21 Oct 2026
P/E (TTM)
17.9
Diluted EPS TTM 1.49 · TTM to 30 Sept 2026
E/P (TTM)
5.60%
TTM to 30 Sept 2026
Dividend yield
3.24%
DPS 12m 0.86
Beta (2y)
0.74
Volatility (1y) 41%
52-week range
17.0226.54

Price history

Loading chart…

Technical reading

RSI (14)
75.2
overbought (≥ 70)
Bollinger (20, 2)
18.91 – 27.23
in the upper half of the band · %B 0.92 · band width 36.1%
SMA 50 / 200
22.16 / 21.48
uptrend (price > SMA50 > SMA200)
MACD (12, 26, 9)
1.17 / 0.82
MACD above signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyS&P 500vs S&P 500Vertical median
1 month+25.2%−1.1%+26.3 pp—
3 months+16.2%−0.5%+16.7 pp—
6 months+20.3%+4.4%+15.9 pp—
Year to date+38.8%+12.3%+26.5 pp—
1 year+47.2%+13.5%+33.7 pp+14.2%
3 years+164.3%+76.4%+87.9 pp+144.3%
5 years+34.9%+63.7%−28.8 pp—
Max drawdown (1y)
−19.9%
11 Feb 2026 → 01 Apr 2026
Max drawdown (5y)
−54.9%
20 Apr 2022 → 25 Oct 2023
Compound annual growth (5y)
+6.2%
S&P 500 +10.4%

Price returns, dividends excluded.

Quarterly results

Latest quarter: Q3 2026 · 30 Sept 2026

Revenue
479.6 m USD
+3.3% YoY
Net income
24.9 m USD
−42.1% YoY
Diluted EPS
0.36
−39.0% YoY
net / operating
5.2% / unavailable

Quarterly margins

Quarterly statements · USD

Fiscal yearQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Revenue437.8 m447.7 m458.5 m464.3 m466.7 m462.8 m470.8 m479.6 m
Cost of revenue379.2 m379.7 m455.5 m367.9 m394.6 m386.9 m396.0 m399.2 m
SG&A44.8 m45.0 m49.2 m50.5 m46.2 m42.0 m52.6 m48.5 m
Depreciation & amortisation3.6 m3.9 m5.0 m ≈4.0 m ≈3.9 m3.8 m3.5 m ≈4.1 m ≈
Pre-tax income14.8 m23.9 m-41.9 m57.3 m28.6 m34.5 m31.0 m33.7 m
Income tax2.9 m6.7 m-9.5 m14.4 m-2.7 m8.5 m8.3 m8.9 m
Net income11.9 m17.2 m-32.4 m43.0 m31.2 m26.1 m22.7 m24.9 m
Diluted EPS0.16 ≈0.23-0.440.590.44 ≈0.370.320.36
Operating cash flow36.2 m27.5 m28.8 m ≈71.3 m ≈17.4 m43.7 m21.9 m ≈30.2 m ≈
Capex1.4 m1.7 m1.4 m ≈1.3 m ≈1.4 m1.4 m1.6 m ≈2.1 m ≈
Share repurchases1.0 m7.0 m7.7 m ≈27.3 m ≈19.6 m24.0 m20.9 m ≈11.7 m ≈

≈ derived quarter (cumulative difference / share-days average)

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 8 percentile of its own 40-quarter history (min 13.8, median 26.6, max 106.4; quarters with earnings only).

Fiscal years

Fiscal year20182019202020212022202320242025
Revenue2.0 bn1.8 bn1.8 bn1.6 bn1.7 bn1.7 bn1.7 bn1.8 bn
Revenue YoY+7.6%−8.1%−4.4%−6.7%+2.9%−1.1%+2.7%+7.1%
Net income83.5 m64.6 m98.7 m48.5 m34.2 m38.4 m39.5 m59.1 m
Net income YoY−5.3%−22.7%+52.8%−50.8%−29.5%+12.1%+2.8%+49.6%
Diluted EPS1.120.871.320.650.460.520.530.81
Diluted EPS YoY−5.9%−22.3%+51.7%−50.8%−29.2%+13.0%+1.9%+52.8%
net %4.2%3.5%5.6%3.0%2.0%2.3%2.3%3.2%
Free cash flow75.1 m89.2 m212.9 m31.4 m-13.4 m38.1 m24.5 m139.2 m

Reported results vs expectations

Loading…

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
125.2 m USD
Financial debt
unavailable USD
Net debt
unavailable USD
Equity
510.2 m USD
Total assets
794.3 m USD
Debt / equity
unavailable
Current ratio
3.38x
ROE
11.7%
ROA
7.4%
FCF margin
7.6%

Financial statements (source on every figure)

Revenue and net income (USD)

Margins

Income statement · USD

Revenue
2023
1.7 bn
2024
1.7 bn
2025
1.8 bn

SEC (XBRL)· 13 Feb 2026verified

Cost of revenue
2023
1.5 bn
2024
1.5 bn
2025
1.6 bn

SEC (XBRL)· 13 Feb 2026verified

Gross profit
2023
214.7 m ≈
2024
228.1 m ≈
2025
239.4 m ≈

SEC (XBRL)· 13 Feb 2026derived

SG&A
2023
166.8 m
2024
183.1 m
2025
190.9 m

SEC (XBRL)· 13 Feb 2026verified

Depreciation & amortisation
2023
14.3 m
2024
14.6 m
2025
16.8 m

SEC (XBRL)· 13 Feb 2026verified

Pre-tax income
2023
53.1 m
2024
52.9 m
2025
67.9 m

SEC (XBRL)· 13 Feb 2026verified

Income tax
2023
14.7 m
2024
13.5 m
2025
8.8 m

SEC (XBRL)· 13 Feb 2026verified

Net income
2023
38.4 m
2024
39.5 m
2025
59.1 m

SEC (XBRL)· 13 Feb 2026verified

Diluted EPS
2023
0.52
2024
0.53
2025
0.81

SEC (XBRL)· 13 Feb 2026verified

Weighted average diluted shares
2023
74.3 m
2024
74.0 m
2025
73.0 m

SEC (XBRL)· 13 Feb 2026verified

Dividend per share
2023
—
2024
—
2025
—

SEC (XBRL)· 17 Feb 2023verified

Balance sheet · USD

Cash
2023
54.3 m
2024
56.8 m
2025
125.2 m

SEC (XBRL)· 13 Feb 2026verified

Receivables
2023
344.9 m
2024
330.9 m
2025
281.3 m

SEC (XBRL)· 13 Feb 2026verified

Inventories
2023
—
2024
—
2025
16.8 m

SEC (XBRL)· 24 Jul 2026verified

Current assets
2023
571.7 m
2024
556.7 m
2025
576.4 m

SEC (XBRL)· 13 Feb 2026verified

Goodwill
2023
75.5 m
2024
75.5 m
2025
79.8 m

SEC (XBRL)· 13 Feb 2026verified

Intangibles (excl. goodwill)
2023
12.1 m
2024
9.4 m
2025
7.0 m

SEC (XBRL)· 13 Feb 2026verified

Total assets
2023
790.7 m
2024
802.8 m
2025
794.3 m

SEC (XBRL)· 13 Feb 2026verified

Accounts payable
2023
83.2 m
2024
81.1 m
2025
77.4 m

SEC (XBRL)· 13 Feb 2026verified

Current liabilities
2023
216.9 m
2024
192.5 m
2025
170.4 m

SEC (XBRL)· 13 Feb 2026verified

Equity
2023
456.6 m †
2024
499.9 m †
2025
510.2 m †

SEC (XBRL)· 13 Feb 2026verified

Cash flow · USD

Operating cash flow
2023
43.5 m
2024
30.8 m
2025
145.0 m

SEC (XBRL)· 13 Feb 2026verified

Capex
2023
5.4 m
2024
6.3 m
2025
5.8 m

SEC (XBRL)· 13 Feb 2026verified

Free cash flow
2023
38.1 m ≈
2024
24.5 m ≈
2025
139.2 m ≈

SEC (XBRL)· 13 Feb 2026derived

Investing cash flow
2023
-3.3 m
2024
6.0 m
2025
-11.0 m

SEC (XBRL)· 13 Feb 2026verified

Financing cash flow
2023
-12.2 m
2024
-31.0 m
2025
-63.3 m

SEC (XBRL)· 13 Feb 2026verified

Dividends paid
2023
0
2024
0
2025
—

SEC (XBRL)· 14 Feb 2025verified

Share repurchases
2023
11.3 m
2024
5.0 m
2025
61.6 m

SEC (XBRL)· 13 Feb 2026verified

Computed indicators

Growth

Revenue growth (YoY)
7.1%
computed by olivLawFY 2025
Revenue CAGR 3Y
2.8%
computed by olivLawFY 2022 → FY 2025
Revenue CAGR 5Y
0.9%
computed by olivLawFY 2020 → FY 2025
EBIT growth (YoY)
unavailable
input data missing
Net income growth (YoY)
49.6%
computed by olivLawFY 2025
Net income CAGR 3Y
19.9%
computed by olivLawFY 2022 → FY 2025
Net income CAGR 5Y
-9.8%
computed by olivLawFY 2020 → FY 2025
EPS growth (YoY)
52.8%
computed by olivLawFY 2025
EPS CAGR 3Y
20.8%
computed by olivLawFY 2022 → FY 2025
EPS CAGR 5Y
-9.3%
computed by olivLawFY 2020 → FY 2025
FCF growth (YoY)
468.7%
computed by olivLawFY 2025

Profitability

Gross margin
16.1%
computed by olivLawTTM to 30 Sept 2026
EBITDA margin
unavailable
input data missing
EBIT margin
unavailable
input data missing
Net margin
5.6%
computed by olivLawTTM to 30 Sept 2026
FCF margin
5.7%
computed by olivLawTTM to 30 Sept 2026

Returns

ROE
20.4%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROA
12.7%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
ROIC
unavailable
input data missing
ROCE
unavailable
input data missing
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
unavailable
input data missing
Net debt / EBITDA
unavailable
input data missing
Debt / equity
unavailable
input data missing
Interest coverage
unavailable
the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used

Liquidity

Current ratio
2.8x
computed by olivLawbalance sheet at 30 Sept 2026
Quick ratio
2.7x
computed by olivLawbalance sheet at 30 Sept 2026
Cash ratio
0.7x
computed by olivLawbalance sheet at 30 Sept 2026

Cash

Operating cash flow
113.2 m USD
computed by olivLawTTM to 30 Sept 2026
Capital expenditure
6.5 m USD
computed by olivLawTTM to 30 Sept 2026
Free cash flow
106.7 m USD
computed by olivLawTTM to 30 Sept 2026
FCF conversion
101.7%
computed by olivLawTTM to 30 Sept 2026
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
58 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days inventory outstanding
4 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Days payables outstanding
20 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Cash conversion cycle
42 days
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

Market and valuation

Market capitalisation
1.8 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
Enterprise value
unavailable
input data missing
Market cap / net income TTM
17.1x
computed by olivLawTTM to 30 Sept 2026
P/E (TTM)
17.9x
computed by olivLawTTM to 30 Sept 2026
Earnings yield
5.6%
computed by olivLawTTM to 30 Sept 2026
P/B
3.4x
computed by olivLawbalance sheet at 30 Sept 2026
P/S
1.0x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
EV/EBITDA
unavailable
input data missing
EV/EBIT
unavailable
input data missing
EV/Sales
unavailable
input data missing
P/FCF
16.8x
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
FCF yield
6.0%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Dividend yield
3.2%
computed by olivLawTTM to 30 Sept 2026
Shareholder yield (distributions)
4.3%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 58.3% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

26.54 USD

04 Nov 2026Source: olivLaw, closing series

Market cap: 1.8 bn USD

Key indicators

Market capitalisation
1.8 bn USD
computed by olivLawbalance sheet at 30 Sept 2026
P/E (TTM)
17.9x
computed by olivLawTTM to 30 Sept 2026
P/B
3.4x
computed by olivLawbalance sheet at 30 Sept 2026
EV/EBITDA
unavailable
input data missing
ROE
20.4%
computed by olivLawTTM to 30 Sept 2026 · balance sheet at 30 Sept 2026
Net margin
5.6%
computed by olivLawTTM to 30 Sept 2026
Revenue growth (YoY)
7.1%
computed by olivLawFY 2025
Dividend yield
3.2%
computed by olivLawTTM to 30 Sept 2026

Coverage and freshness

28/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 30 Sept 2026
Latest balance sheet date: 30 Sept 2026
Share count (cover of the latest filing), as of: 21 Oct 2026
Source: SEC (XBRL)published 23 Oct 2026
verified 2298derived 159

Score by group

58% · Insufficient data

Estimated value range

Low
24.92
USD per share
Mid
27.26
USD per share
High
28.40
USD per share
Price: 26.54 USD
The price is within the range
Potential to the central value: 2.7% (value / price − 1)
Margin of safety: 2.7% (1 − price / value)
Agreement between methods: low · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 11.30 – 41.61 USD.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (USD per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)unavailable · the reported interest expense is far older than the latest period (the filer changed its XBRL tag): a stale figure is not used
  • Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
  • Peers: P/E38.54 – 41.61 (Mid 41.56)
    3 companies used · median multiple 28.0x · quartiles 25.9x – 28.0x
    ENSG, NHC, PACS
  • Dividend discount (DDM)11.30 – 15.20 (Mid 12.96)
Multiple comparisons use the SIC vertical: Health services (SIC 805x)

Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.

Assumptions (illustrative, editorial)

Risk-free rate
4.3%
Equity risk premium
5.0%
Beta (default)
1.00
Cost of equity
9.3%
Terminal growth
2.5%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 58.3% of at least 60%

FactorValueScoreWeight used
ROIC · Qualityunavailableunavailable—
Net margin · Quality5.6%60 (vs peers)11%
FCF conversion · Quality101.7%100 (on a fixed band)11%
Revenue CAGR 3Y · Growth2.8%23 (on a fixed band)14%
EPS CAGR 3Y · Growth20.8%100 (on a fixed band)14%
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheetunavailableunavailable—
Current ratio · Balance sheet2.8x100 (on a fixed band)7%
P/E (TTM) · Valuation17.9x55 (on a fixed band)18%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation6.0%75 (on a fixed band)14%
Shareholder yield (distributions) · Returns4.3%61 (on a fixed band)11%
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet· partial100/100 · 1/3 factors with a value
  • Growth62/100 · 2/2 factors with a value
  • Quality80/100 · 2/3 factors with a value
  • Returns· partial61/100 · 1/2 factors with a value
  • Valuation64/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

HEALTHCARE SERVICES GROUP, INC. (HCSG). Latest full fiscal year: 2025; data up to 2026-09-30.

Figures computed from the financial statements: revenue 1.8 bn USD in 2025; YoY growth 7.1%; net margin 5.6%; ROE 20.4%.

The estimated value range is 24.92–28.40 USD per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 27.26 USD, the price of 26.54 USD leaves a potential of 2.7% (value / price − 1) and a margin of safety of 2.7% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 58.3% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF conversion: 101.7%
  • EPS CAGR 3Y: 20.8%
  • Current ratio: 2.8x
  • FCF yield: 6.0%

What contradicts it

  • Revenue CAGR 3Y: 2.8%
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): ROIC, Net debt / EBITDA, Interest coverage, EV/EBITDA, Payout ratio (FCF).

Versus the vertical median

Health services (SIC 805x) · same industry group (3-digit SIC) · compared with 5 companies

Multiples and returns vs the median

P/E
17.9x
vertical median 28.0x
below median (−36.1%)
EV/EBITDA
—
vertical median 17.2x
P/S
1.0x
vertical median 1.9x
below median (−50.8%)
P/B
3.4x
vertical median 3.6x
below median (−7.2%)
ROE
20.4%
vertical median 13.1%
above median (+56.0%)
Net margin
5.6%
vertical median 4.9%
above median (+14.7%)
EBIT margin
—
vertical median 8.2%
Revenue YoY
7.1%
vertical median 18.7%
below median (−62.2%)
Net debt/EBITDA
—
vertical median -0.2x
Dividend yield
3.2%
vertical median 0.4%
above median (+649.5%)

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ENSGEnsign Group, Inc11.0 bn28.017.1%7.0%+18.7%+1% / +76%
PACSPACS Group, Inc.8.0 bn28.026.6%4.9%+29.3%+50% / unavailable
NHCNational Healthcare Corp3.3 bn23.913.1%9.0%+16.1%+56% / +177%
BKDBrookdale Senior Living Inc.2.7 bn—-362.1%-4.5%+2.2%+1% / +111%
HCSGHealthcare Services Group, Inc.1.8 bn17.920.4%5.6%+7.1%+47% / +164%
SNDASonida Senior Living, Inc.1.8 bn—-26.7%-23.3%+25.2%+14% / +282%

1- and 3-year price returns: for HCSG from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (USD)

Estimated priceBearBaseBull
1 years
16.14
Total return -39% · Per year -39%
28.56
Total return 8% · Per year 8%
43.05
Total return 62% · Per year 62%
3 years
15.14
Total return -43% · Per year -17%
30.19
Total return 14% · Per year 4%
50.04
Total return 89% · Per year 24%
5 years
14.20
Total return -46% · Per year -12%
31.92
Total return 20% · Per year 4%
58.17
Total return 119% · Per year 17%
What moves the 3-year price the most
  • Exit P/E± 7.55
  • Net margin± 5.28
  • Annual revenue growth± 4.41
  • Annual dilution± 0.44

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Healthcare Services Group provides housekeeping, laundry, facility maintenance and dietary services to healthcare and long-term care facilities across the United States, and says it is the largest provider of such services to the long-term care industry. Its focus on institutional operational services has been tested by the bankruptcy of a major customer, yet the company reports accelerating growth, with revenue of 1,837.2 million USD in 2025 and 479.6 million USD in the third quarter of 2026.

SWOT

Strengths

  • The company presents itself as the largest provider of housekeeping, laundry and dietary services to the long-term care industry in the United States, with a broad customer base and a strong market position 1.
  • Liquidity is solid, with substantial cash and marketable securities and an unused credit line, giving flexibility for acquisitions and share repurchases 3.
  • Organic revenue growth and the raised outlook for 2027 point to stronger operational execution in recent quarters 23.

Weaknesses

  • Dependence on long-term care customers that rely on government funding makes the company vulnerable to regulatory changes and customer payment difficulties 1.
  • Margins are sensitive to labor and food costs, and the ability to pass these costs to customers is not always immediate 1.
  • Exposure to a major customer produced significant bad debt charges in 2025, which weighed on that year's profitability 1.

Opportunities

  • The NEXDINE acquisition opens access to senior living and hospitality, segments that could accelerate growth if integration proceeds as planned 3.
  • Favorable demographic trends and rising demand for care services could support expansion into new customer facilities 3.
  • Genesis bankruptcy recoveries above current estimates could improve future results if they materialize 23.

Threats

  • Tariffs and inflation could raise supply and food costs, and the company may be unable to fully pass them to customers 1.
  • Bankruptcies or financial difficulties among major customers could lead to credit losses and lower revenue 1.
  • Changes to Medicare and Medicaid reimbursement could reduce customer revenues and their ability to pay for services 1.

Risks

  • Customer concentrationhigh

    A small number of customers contribute significantly to revenue, and the bankruptcy of a major customer has already affected the company's financial results 1.

  • Customer credit riskhigh

    The company extends credit to substantially all customers, and deterioration in their financial condition can increase bad debt losses, as occurred in 2025 1.

  • Labor cost pressuremedium

    Hourly wages are affected by minimum wage laws and collective bargaining, and passing these increases through to customers may be delayed 1.

  • Tariffs and supply costsmedium

    Tariffs can raise the cost of supplies and food, and the sources note reliance on a limited number of vendors for a substantial portion of supplies 1.

  • Acquisition integrationlow

    The NEXDINE acquisition brings new activities and integration risks, and the announced benefits depend on subsequent execution 3.

Investment thesis

What would need to be true (bull case)

  • The company holds a self-described leading position in its niche and a broad base of institutional customers, giving it an advantage of scale 1.
  • Organic revenue growth and the raised 2027 growth outlook suggest management sees an acceleration in the core business 23.
  • The NEXDINE acquisition could open new growth sources in senior living and hospitality if integration succeeds 3.

What would break the thesis

  • Reliance on government-funded customers and their risk of bankruptcy could lead to further bad debt losses, as recently occurred 1.
  • Operating margins are under pressure from labor and supply costs, and passing these costs to customers may be delayed 1.
  • The new segments carry execution risk and may require additional investment and management attention, which could limit the benefits of the acquisition 3.

What to watch

  • Delivery of the fourth-quarter revenue guidanceQ4 2026
  • NEXDINE contribution to revenue and margins after integration2027
  • Final recoveries from the Genesis bankruptcy proceedingsnext 10-K
  • Effect of labor costs and tariffs on margins2027

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

The company manages the housekeeping, laundry, linen, facility maintenance and dietary departments of its customers, mainly nursing homes, rehabilitation centers, retirement complexes and hospitals. Services are delivered mainly under full-service agreements, in which the company handles day-to-day management of employees and certain supplies, and contracts are typically renewable and cancellable on 30 to 90 days' notice. The annual report says it served about 2,800 facilities at December 31, 2025, and the third-quarter filing says more than 2,700 at September 30, 2026 12.

Revenue depends on winning new customers, expanding services to existing ones and passing cost increases into service billings. Labor is the main cost driver, and supplies weigh more heavily on Dietary. The company also recognized ERC payroll tax credit income in 2025 and bad debt expense tied to the Genesis bankruptcy 1.

In October 2026 the company acquired NEXDINE Hospitality, a senior living and hospitality services business, for an upfront price of 93.5 million USD paid from cash, extending its platform from healthcare toward hospitality and senior living 23. The company now describes itself as a health and hospitality services platform, with its customer base expanding beyond long-term care.

Segments

Environmental Services (EVS)

The EVS segment manages housekeeping, disinfection, laundry and linen services in customer facilities, generating 824.7 million USD in 2025, or 44.9% of revenue 1. Labor makes up most segment costs, and EVS revenue rose 2.6% in the third quarter of 2026, supported by client wins and retention 2.

Dietary

The Dietary segment handles food purchasing, meal preparation and dietitian services for residents, generating 1,012.5 million USD in 2025, or 55.1% of revenue 1. Food costs are sensitive to commodity prices and tariffs, and Dietary revenue rose 3.9% in the third quarter of 2026 2.

Market context

The core market is operational services for healthcare providers in the United States, particularly long-term care operators whose revenues depend heavily on Medicare and Medicaid funding. The company says it is the largest provider of housekeeping, laundry and dietary management to this sector, and its customers are concentrated in a regulated industry 12.

Expansion into senior living and hospitality opens a broader but more competitive market in which the company hopes to apply its healthcare operating expertise 3. If demographic growth in the older population translates into demand for these services, it could support longer-term expansion.

Trends

  • Inflation and tariff pressureheadwind

    Tariffs and inflationary pressures could raise the cost of supplies and food products, and the company may not always pass such increases to customers quickly 1.

  • Rising demand for long-term caretailwind

    The company says the industry is at the start of a multi-decade demographic tailwind that could support demand for its services 3.

  • Financial health of customersmixed

    Customers depend on Medicare and Medicaid funding, and regulatory changes can affect their cash flows and payment ability, raising credit risk for the company 1.

  • Expansion into hospitality and senior livingmixed

    The NEXDINE acquisition and the unified platform strategy could open new markets, but integration and diversification also carry execution risk 23.

Competitive position

The main competition comes from customers' in-house support staff, who may handle these functions themselves, as well as several regional and national firms offering similar services 1. The company differentiates itself through cost-effectiveness and by relieving customers of day-to-day administrative burdens 1.

In the newer senior living and hospitality segments, competition may include specialized dining and hospitality operators, but the available sources do not explicitly identify publicly listed US competitors 3.

  • Customers' in-house support staff

    Facilities can run housekeeping and dietary functions with their own personnel, which is the most direct alternative to outsourcing 1.

  • Regional and national housekeeping and dietary service firms

    The filing refers to several firms competing in regional and national markets without naming them 1.

  • Specialized senior living dining providers

    As the company enters senior living and hospitality, specialized dining and hospitality providers may compete, though the sources do not name them 3.

  • Senior living and hospitality operators

    Operators of senior housing and hotels may be competitors or partners in the new segment, but the sources do not identify them 3.

News & filings

In the press

No news in our archive over the last 180 days.

SEC filings

Sources

  1. [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Healthcare Services Group, Inc. · 13 Feb 2026
  2. [2] Form 10-Q, quarter ended 2026-09-30 · SEC / Healthcare Services Group, Inc. · 23 Oct 2026
  3. [3] Form 8-K, results release (exhibit 99.1) · SEC / Healthcare Services Group, Inc. · 21 Oct 2026

Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.

Healthcare Services Group, Inc. (HCSG): stock, results, valuation and forecast · olivLaw